000 | 01950 a2200457 4500 | ||
---|---|---|---|
005 | 20250516200554.0 | ||
264 | 0 | _c20151123 | |
008 | 201511s 0 0 eng d | ||
022 | _a1477-092X | ||
024 | 7 |
_a10.1177/1078155214522840 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSessink, Paul J M | |
245 | 0 | 0 |
_aEnvironmental contamination, product contamination and workers exposure using a robotic system for antineoplastic drug preparation. _h[electronic resource] |
260 |
_bJournal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners _cApr 2015 |
||
300 |
_a118-27 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAir Pollutants, Occupational _xadverse effects |
650 | 0 | 4 |
_aAntineoplastic Agents, Alkylating _xadministration & dosage |
650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
650 | 0 | 4 |
_aDrug Compounding _xadverse effects |
650 | 0 | 4 |
_aDrug Contamination _xprevention & control |
650 | 0 | 4 | _aEnvironment, Controlled |
650 | 0 | 4 |
_aEnvironmental Monitoring _xmethods |
650 | 0 | 4 |
_aEquipment Contamination _xprevention & control |
650 | 0 | 4 | _aEquipment Design |
650 | 0 | 4 | _aGloves, Protective |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInfusions, Intravenous |
650 | 0 | 4 |
_aOccupational Exposure _xadverse effects |
650 | 0 | 4 | _aPharmacy Service, Hospital |
650 | 0 | 4 | _aRisk Assessment |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aRobotics |
700 | 1 | _aLeclercq, Gisèle M | |
700 | 1 | _aWouters, Dominique-Marie | |
700 | 1 | _aHalbardier, Loïc | |
700 | 1 | _aHammad, Chaïma | |
700 | 1 | _aKassoul, Nassima | |
773 | 0 |
_tJournal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners _gvol. 21 _gno. 2 _gp. 118-27 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1177/1078155214522840 _zAvailable from publisher's website |
999 |
_c23583493 _d23583493 |